Biotech Markets on the move. June 2013

Biotech Markets on the move. June 2013

- Bluebird Bio raises $101M in upsized IPO. Opens at $25.50 (BLUE).
- Prosensa amends IPO and sets price range (RNA).
- FDA to review BLA from Pharming/Santarus.
- Exact Sciences raises $67.9M in follow-on.
- Royalty Pharma ends hostile bid for Elan.
- AstraZeneca and NGM Pharma sign deal to develop diabetes drugs.

[Read more...]